Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
3R01MH050038-02S1
Application #
2249402
Study Section
Mental Disorders of Aging Review Committee (MDA)
Project Start
1994-05-01
Project End
1999-04-30
Budget Start
1995-05-01
Budget End
1996-04-30
Support Year
2
Fiscal Year
1995
Total Cost
Indirect Cost
Name
New York State Psychiatric Institute
Department
Type
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Pelton, Gregory H; Soleimani, Laili; Roose, Steven P et al. (2016) Olfactory Deficits Predict Cognitive Improvement on Donepezil in Patients With Depression and Cognitive Impairment: A Randomized Controlled Pilot Study. Alzheimer Dis Assoc Disord 30:67-9
Devanand, D P; Bansal, Ravi; Liu, Jun et al. (2012) MRI hippocampal and entorhinal cortex mapping in predicting conversion to Alzheimer's disease. Neuroimage 60:1622-9
Albers, Mark W; Tabert, Matthias H; Devanand, D P (2006) Olfactory dysfunction as a predictor of neurodegenerative disease. Curr Neurol Neurosci Rep 6:379-86
Tabert, Matthias H; Liu, Xinhua; Doty, Richard L et al. (2005) A 10-item smell identification scale related to risk for Alzheimer's disease. Ann Neurol 58:155-60
Tabert, M H; Albert, S M; Borukhova-Milov, L et al. (2002) Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology 58:758-64
Albert, Steven M; Tabert, Matias H; Dienstag, Alan et al. (2002) The impact of mild cognitive impairment on functional abilities in the elderly. Curr Psychiatry Rep 4:64-8
Devanand, D P; Michaels-Marston, K S; Liu, X et al. (2000) Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. Am J Psychiatry 157:1399-405
Albert, S M; Michaels, K; Padilla, M et al. (1999) Functional significance of mild cognitive impairment in elderly patients without a dementia diagnosis. Am J Geriatr Psychiatry 7:213-20
Devanand, D P (1999) The interrelations between psychosis, behavioral disturbance, and depression in Alzheimer disease. Alzheimer Dis Assoc Disord 13 Suppl 2:S3-8
Devanand, D P; Marder, K; Michaels, K S et al. (1998) A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease. Am J Psychiatry 155:1512-20

Showing the most recent 10 out of 11 publications